Halozyme Appoints David Ramsay as Interim Chief Financial Officer

AI Briefing

• – Halozyme Therapeutics appoints David Ramsay as Interim CFO, effective March 23, 2026.
• – Mr. Ramsay will oversee all financial operations.
• – No further details provided.